Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group
- PMID: 34763056
- PMCID: PMC8572734
- DOI: 10.1016/j.cmi.2021.10.011
Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group
Keywords: EU-RESPOSE; Financial hurdles; Legal hurdles; Platform trials; Regulatory hurdles.
Figures
References
-
- Mullard A. COVID-19 platform trial delivers. Nat Rev Drug Discov. 2020;19:501. - PubMed
-
- Woodcock J., LaVange L.M. Master protocols to study multiple therapies, multiple diseases, or both. N Engl J Med. 2017;377:62–70. - PubMed
-
- WHO COVID-19 solidarity therapeutics trial. World Health Organization; 2021. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-r... accessed July 2021. Available at:
-
- National Institute for Health Research (NIHR) – Written evidence (COV0041) https://committees.parliament.uk/writtenevidence/8275/pdf/ Available at:
MeSH terms
LinkOut - more resources
Full Text Sources
Medical